DE3486442D1 - Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür - Google Patents

Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür

Info

Publication number
DE3486442D1
DE3486442D1 DE3486442T DE3486442T DE3486442D1 DE 3486442 D1 DE3486442 D1 DE 3486442D1 DE 3486442 T DE3486442 T DE 3486442T DE 3486442 T DE3486442 T DE 3486442T DE 3486442 D1 DE3486442 D1 DE 3486442D1
Authority
DE
Germany
Prior art keywords
menopause
peri
disorders
packaging
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3486442T
Other languages
English (en)
Other versions
DE3486442T3 (de
DE3486442T2 (de
Inventor
Earl Robert Plunkett
Bernard Martin Joseph Wolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pre Jay Holdings Ltd
Original Assignee
Pre Jay Holdings Ltd
Woco Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3486442(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pre Jay Holdings Ltd, Woco Investments Ltd filed Critical Pre Jay Holdings Ltd
Application granted granted Critical
Publication of DE3486442D1 publication Critical patent/DE3486442D1/de
Publication of DE3486442T2 publication Critical patent/DE3486442T2/de
Anticipated expiration legal-status Critical
Publication of DE3486442T3 publication Critical patent/DE3486442T3/de
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3486442T 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür Expired - Lifetime DE3486442T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US520834 1983-08-05
US635236 1984-07-27
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (3)

Publication Number Publication Date
DE3486442D1 true DE3486442D1 (de) 1997-03-06
DE3486442T2 DE3486442T2 (de) 1997-06-05
DE3486442T3 DE3486442T3 (de) 2005-05-12

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
DE10199001C Active DE10199001I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE3486442T Expired - Lifetime DE3486442T3 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10199010C Active DE10199010I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10075037C Active DE10075037I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE1997175086 Active DE19775086I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonalen Behandlung von Stoerungen in der Peri-Menopause Menopause und Post-Menopause und Verpackung mit multiplen Praeparaten dafuer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10199001C Active DE10199001I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE10199010C Active DE10199010I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10075037C Active DE10075037I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE1997175086 Active DE19775086I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonalen Behandlung von Stoerungen in der Peri-Menopause Menopause und Post-Menopause und Verpackung mit multiplen Praeparaten dafuer

Country Status (12)

Country Link
US (2) US4826831A (de)
EP (1) EP0136011B2 (de)
AT (1) ATE147987T1 (de)
CA (1) CA1240927A (de)
DE (5) DE10199001I2 (de)
DK (2) DK165390C (de)
IL (1) IL72556A (de)
LU (5) LU90107I2 (de)
MX (1) MX9203720A (de)
NL (5) NL970026I1 (de)
NZ (1) NZ209066A (de)
PH (1) PH24052A (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ATE66149T1 (de) * 1987-07-06 1991-08-15 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (de) * 1987-12-22 1989-06-28 Akzo N.V. Pharmazeutische Dosierungseinheit zur Behandlung von klimakterischen Beschwerden und Osteoporosis
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
PH30747A (en) * 1989-03-10 1997-10-17 Endorech Inc Combination therapy for the treatment of estrogen sensitive disease.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1098653A2 (de) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
CA2311937A1 (en) * 1998-10-09 2000-04-20 Pharmacia & Upjohn Company Llc Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) * 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
JP2004524354A (ja) * 2001-03-16 2004-08-12 ワイス エストロゲン補充療法
IL157944A0 (en) * 2001-03-16 2004-03-28 Wyeth Corp Hormone replacement therapy
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
WO2002092102A2 (en) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
WO2003006027A1 (en) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
PT1453521E (pt) 2001-12-05 2013-10-08 Teva Womens Health Inc Contracetivos orais para prevenir a gravidez e diminuir a sintomatologia pré-menstrual
US20030216366A1 (en) * 2002-04-03 2003-11-20 Leonard Thomas W. Step-down estrogen therapy
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
RU2340345C2 (ru) * 2002-08-28 2008-12-10 Роберт КАСПЕР Схема восполнения эстрогена
EP1462106A1 (de) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmazeutishe Zusammensetzungen und Kits enthaltend 17-Betaestradiol und Progesteron zur Behandlung von Gynäcologischen Storungen
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
WO2004098517A2 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004275470B2 (en) * 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
PT1670440E (pt) * 2003-09-29 2014-08-22 Novo Nordisk Femcare Ag Formulações hrt
CA2566811A1 (en) * 2004-05-26 2005-12-15 Wyeth Compositions and methods for treatment of premenstrual dysphoric disorder
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
JP2009521533A (ja) * 2005-12-27 2009-06-04 デュラメド ファーマシューティカルズ インコーポレーティッド 結合型エストロゲン組成物、アプリケーター、キット、ならびにそれらの作製および使用の方法
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
EP2164498A4 (de) 2007-06-04 2010-09-08 Univ California Schwangerschaftshormonkombination zur behandlung von autoimmunkrankheiten
CA2795801C (en) 2010-04-15 2018-05-29 Bayer Intellectual Property Gmbh Very low-dosed solid oral dosage forms for hrt
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3137088B1 (de) 2014-04-28 2023-08-30 The Regents of The University of California Pharmazeutische verpackung für estrioltherapie zur behandlung von multipler sklerose
EP3137087B1 (de) 2014-04-28 2023-09-06 The Regents of the University of California Östrogenkombination zur behandlung von multipler sklerose
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2016036719A1 (en) 2014-09-02 2016-03-10 The Regents Of The University Of California Estrogen therapy for brain gray matter atrophy and associated disability
ES2957543T3 (es) 2014-09-29 2024-01-22 Univ California Composiciones y métodos para mantener la función cognitiva
WO2016160832A1 (en) 2015-03-30 2016-10-06 The Regents Of The University Of California Methods of monitoring estriol therapy
EA035687B1 (ru) 2015-06-18 2020-07-27 Эстетра Спрл Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
LU91096I2 (fr) 2004-11-30
NZ209066A (en) 1988-01-08
DK377084A (da) 1985-02-06
EP0136011A3 (de) 1986-07-16
DE3486442T3 (de) 2005-05-12
PH24052A (en) 1990-03-05
NL300033I2 (nl) 2004-04-01
IL72556A (en) 1989-05-15
DE3486442T2 (de) 1997-06-05
DE10199010I1 (de) 2002-05-08
US4826831A (en) 1989-05-02
DK165390C (da) 2004-04-26
EP0136011B2 (de) 2004-06-09
LU90697I2 (fr) 2001-02-13
DE10075037I1 (de) 2001-03-01
DK377084D0 (da) 1984-08-03
CA1240927A (en) 1988-08-23
NL300022I2 (nl) 2004-04-01
ATE147987T1 (de) 1997-02-15
DE10199010I2 (de) 2010-01-28
DK175317B1 (da) 2004-08-16
NL970026I1 (nl) 1997-10-01
NL300033I1 (nl) 2001-03-01
DK165390B (da) 1992-11-23
LU90696I2 (fr) 2001-02-13
DE19775086I2 (de) 2001-08-23
MX9203720A (es) 1992-07-31
DK200400365A (da) 2004-03-04
NL970037I1 (nl) 1998-02-02
LU90343I2 (fr) 1999-03-29
NL980038I1 (nl) 1999-02-01
NL300022I1 (nl) 2001-01-02
DE10199001I2 (de) 2010-07-08
LU90107I2 (fr) 1997-12-17
NL980038I2 (nl) 2005-06-01
NL970037I2 (nl) 2004-04-01
IL72556A0 (en) 1984-11-30
DE10199001I1 (de) 2002-03-14
USRE36247E (en) 1999-07-06
DE10075037I2 (de) 2010-01-28
EP0136011B1 (de) 1997-01-22
EP0136011A2 (de) 1985-04-03

Similar Documents

Publication Publication Date Title
DE3486442D1 (de) Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
EP0148396A3 (en) Apparatus for producing gallium arsenide single crystal and gallium arsenide single crystal produced by said apparatus
JPS5259124A (en) Photopolymerizable unsaturated ketones and process for preparation thereof
CH469693A (de) Verfahren zur Herstellung von in 3-Stellung substituierten 2-Amino-2,3-dihydro-5-benzofuranolen und deren (2-Aminoäthyl)hydrochinon-hydrogenolyseprodukten
JPS51151390A (en) Process for preparing long chain alpha-oxycarboxylic acids
IL50023A (en) 1-methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles and process for their manifacture
JPS521359A (en) Fixing process of lock bolt and its lock bolt
SU557064A1 (ru) Глазурь
ES2044958T3 (es) Metodo de tratamiento sinergico.
NL174544C (nl) Werkwijze voor de bereiding van een (ar)alkaancarbonzuur uit een aralkeen en een (ar)alkaancarbonzuuranhydride.
JPS5259470A (en) Apparatus for separating and supplying bundled shape steels
JPS521807A (en) Noise reducing apparatus of railway vehicle
JPS5233608A (en) Process for preparation of aminopropanediol derivatives
JPS51113245A (en) Method for manufacturing internal box of refrigieter
AT343559B (de) Verfahren zur behandlung von abwasser, insbesondere von abwasser, welches vom wirbelschicht-cracken stickstoffhaltiger kohlenwasserstoffole stammt
JPS5242850A (en) Process for preparation of novel allenediol and its derivatives
JPS526655A (en) Method for killing insects in garbage vessel
JPS51138841A (en) Dc feed system

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PRE JAY HOLDINGS LTD., LONDON, ONTARIO, CA WOCO IN

V448 Application of spc

Free format text: PRODUCT NAME: KONJUGIERTE ESTROGENE VOM PFERD MIT MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: 29838.00.00, 29838.01.00, 37549.00.00, 37549.01.00; 19970430

Spc suppl protection certif: 197 75 086

Filing date: 19971023

8363 Opposition against the patent
V448 Application of spc

Free format text: PRODUCT NAME: KOMBINATION VON 1 MG ESTRADIOL (ALS HALBHYDRAT) UND 0,5 MG NORETHISTERONACETAT; REGISTRATION NO/DATE: 43555.00.00, 19980812

Spc suppl protection certif: 199 75 002

Filing date: 19990108

V448 Application of spc

Free format text: PRODUCT NAME: KOMBINATION VON ESTRADIOL-VALERAT UND MEDROXYPROGESTERON-ACETAT; REGISTRATION NO/DATE: 48946.00.00, 48946.01.00, 48947.00.00; 20000804

Spc suppl protection certif: 100 75 037

Filing date: 20001215

V448 Application of spc

Free format text: PRODUCT NAME: KOMBINATION VON ETHINYLESTRADIOL UND NORETHISTERON-ACETAT; REGISTRATION NO/DATE: 48848.00.00, 20000706

Spc suppl protection certif: 101 99 001

Filing date: 20010103

V448 Application of spc

Free format text: PRODUCT NAME: ESTRADIOL-HEMIHYDRAT MIT DYDROGESTERON; REGISTRATION NO/DATE: 49942.00.00, 20001113

Spc suppl protection certif: 101 99 010

Filing date: 20010131

V457 Spc granted

Free format text: PRODUCT NAME: KONJUGIERTE ESTROGENE VOM PFERD MIT MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: 29838.00.00, 29838.01.00, 37549.00.00, 37549.01.00; 19970430

Spc suppl protection certif: 197 75 086

Filing date: 19971023

8325 Change of the main classification

Ipc: A61K 31/57

8325 Change of the main classification

Ipc: A61K 31565

8366 Restricted maintained after opposition proceedings
V484 Delivery of the decision of grant

Free format text: PRODUCT NAME: KOMBINATION VON 1 MG ESTRADIOL (ALS HALBHYDRAT) UND 0,5 MG NORETHISTERONACETAT; REGISTRATION NO/DATE: 43555.00.00, 19980812

Spc suppl protection certif: 199 75 002

Filing date: 19990108

V464 Spc expired

Free format text: PRODUCT NAME: KONJUGIERTE ESTROGENE VOM PFERD MIT MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: 29838.00.00, 29838.01.00, 37549.00.00, 37549.01.00; 19970430

Spc suppl protection certif: 197 75 086

Filing date: 19971023

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: KOMBINATION VON ESTRADIOL-VALERAT UND MEDROXYPROGESTERON-ACETAT; REGISTRATION NO/DATE: 48946.00.00, 48946.01.00, 48947.00.00; 20000804

Spc suppl protection certif: 100 75 037

Filing date: 20001215

Free format text: PRODUCT NAME: ESTRADIOL-HEMIHYDRAT MIT DYDROGESTERON; REGISTRATION NO/DATE: 49942.00.00, 20001113

Spc suppl protection certif: 101 99 010

Filing date: 20010131

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: KOMBINATION VON 1 MG ESTRADIOL (ALS HALBHYDRAT) UND 0,5 MG NORETHISTERONACETAT; RE. NO/DATE: 43555.00.00 29980812

Spc suppl protection certif: 199 75 002

Filing date: 19990108

Free format text: PRODUCT NAME: KOMBINATION VON ETHINYLESTRADIOL UND NORETHISTERON-ACETAT; REGISTRATION NO/DATE: 48848.00.00, 20000706

Spc suppl protection certif: 101 99 001

Filing date: 20010103

Free format text: PRODUCT NAME: KOMBINATION VON 1 MG ESTRADIOL (ALS HALBHYDRAT) UND 0,5 MG NORETHISTERONACETAT; REGISTRATION NO/DATE: 43555.00.00, 19980812

Spc suppl protection certif: 199 75 002

Filing date: 19990108